Weekly Brief | 06.04.26
 
 
Chainalysis Research and Analysis
 
 

The massive demand for GLP-1 weight-loss drugs like Ozempic and Wegovy has birthed a sprawling "gray market" of overseas suppliers. Shut out by traditional banks and credit card processors, this industry has adopted cryptocurrency as its financial backbone and it’s now experiencing a massive breakout fueled by a viral internet subculture. But blockchain data reveals a dark evolution in the supply chain. Key insights include:

  • The on-chain gray-market peptide industry has surged past a $100 million annual run rate in recent months.
  • What began as a niche biohacker community is now saturated by a TikTok-driven subculture obsessed with physical enhancement, drawing in a massive wave of teenage retail buyers.
  • As retail consumers flood the space, independent chemical safety testing has collapsed. Buyers are now injecting unverified compounds based on vendor-supplied purity reports that ignore critical sterility risks.
  • On-chain data reveals that some popular gray-market peptide vendors are actually Chinese chemical manufacturers who recently pivoted away from supplying fentanyl and amphetamine precursors to transnational drug cartels to capitalize on this lower-risk, high-reward hype.

Read our full analysis here.

 
 

Recent Insights

 
 
 
 
 
 
 
 
 
 
Who are we?
 
 

Chainalysis is the blockchain data platform, making it easy to connect the movement of digital assets to real-world services. Powered by deep blockchain data and AI, organizations can investigate illicit activity, manage risk exposure, and develop innovative market solutions built on the industry's most trusted blockchain intelligence. Our mission is to build trust in blockchains, blending safety and security with an unwavering commitment to growth and innovation. For more information, visit chainalysis.com.